首页 | 本学科首页   官方微博 | 高级检索  
     


Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation
Authors:Pavel Klener  David Salek  Robert Pytlik  Heidi Mocikova  Kristina Forsterova  Petra Blahovcova  Vit Campr  Vit Prochazka  Ales Obr  Radek Jaksa  Jana Kuntscherova  Ludmila Boudová  Roman Kodet  Andrea Janikova  Marek Trneny
Affiliation:1. First Medical Department, Charles University General Hospital, Prague, Czech Republic;2. Department of Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic;3. Department of Internal Medicine and Haematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic;4. Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Hospital, Motol, Czech Republic;5. Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic;6. Institute of Pathology, Charles University General Hospital, Prague, Czech Republic;7. Department of Pathology, Charles University Medical Faculty Plzen, Prague, Czech Republic
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号